Category: Digital Platform

Evangeli Bista on DION TV: Social Support and Kapa3’s Role in Guiding Oncology Patients

On March 19, 2026, Evangeli Bista, Co-founder of Kapa3, gave an interview to Christos Thanasainas, journalist and Scientific Director of Forlife Clinic, on Central Macedonia’s DION TV, during the daily program All About Health, which covers topics on health, nutrition, autoimmune diseases, and recent scientific developments.

The discussion highlighted the importance of social support for cancer patients and their families, both inside and outside the hospital, as well as the critical role of Kapa3 in guiding and providing holistic support to patients.

WHAT IS SOCIAL SUPPORT – TWO WORLDS:

Social support in cancer care is not a single, uniform concept. Inside the hospital, it mainly concerns assistance with the public healthcare system and bureaucratic procedures. Outside the hospital, real life begins: family, caregivers, and decisions the patient must make.

MAJOR SYSTEM CHALLENGES:

As Ms. Bista noted, hospitals face a significant shortage of social workers and related professionals. International literature suggests that there should be 10 social workers for every 2,500 residents—but this is not the case in Greece. In 92 municipalities, there is not a single social worker, while in areas where social workers exist, most are on fixed-term contracts or funded through programs (such as ESIF). The result is a maze of bureaucracy and uncertainty for the patient, who must understand medical and legal terms, make critical decisions, and manage financial consequences—often without support.

THE ROLE OF KAPA3 – SOLUTION, NOT JUST A SERVICE:

In this environment, Kapa3 provides holistic guidance and support, helping patients navigate procedural and practical issues—either independently, if they feel capable, or with active assistance from the organization at every step. Coverage is nationwide, although the complexity and fragmented structure of the system require ongoing study and time for effective support.

THE “HEAVY” MESSAGE – UNDERSTANDING VS. INFORMATION:

As Ms. Bista emphasized:

“The patient doesn’t need more information – they need understanding.”

The process is essentially behavioral: understanding reduces uncertainty, uncertainty reduces anxiety, anxiety affects behavior, and behavior determines health outcomes.

Kapa3 operates within this “maze,” offering holistic guidance and support. Intervention can be supportive, giving patients the ability to act on their own, or active, guiding them step by step. Kapa3 covers the entire country, addressing the growing needs of patients.

THE BIG CHALLENGE: “MYRTO”

“Myrto” represents Kapa3’s major initiative for 2026. After five years in oncology social support, Kapa3 addresses secondary digital exclusion with “Myrto”—a Digital Health Navigator designed to transform knowledge into practical understanding and provide real-time guidance for patients, avoiding the “chaotic wandering” through the healthcare system. The platform is currently in the study and design phase, aiming to meet the real needs of patients and their caregivers.

The interview highlighted the importance of social support, understanding over mere information, and the role of digital technology in modern oncology care. Kapa3 and Myrto strive to bring care from the hospital into patients’ daily lives through a holistic, personalized, and practical approach.

For more information and to watch the full interview, see the video on YouTube here.

(Note: Video in Greek with no English subtitles).

You can dowload our Press Release here

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3’s Contribution to the 6th Nursing Symposium of Western Macedonia: Digital Health, Empathy, and Patient Navigation

With active participation in a well-established scientific meeting on contemporary nursing issues, Kapa3 took part in the 6th Nursing Symposium of Western Macedonia on “Innovation and Empathy: Balancing Technology with Human Contact in Nursing”, held on March 19–20, 2026, in Ptolemaida.

The Symposium, now a key annual event for the nursing community, serves as a platform for dialogue, knowledge exchange, and highlighting the multifaceted role of nurses in modern healthcare.

As part of the thematic session “Innovation and Citizen Engagement: Creating Accessible Tools with Empathy”, Ms. Evangeli Bista, co-founder of Kapa3, joined the panel along with Ms. Pisti Krystallidou, President of the NGO WinCancer, showcasing the role of civil society in shaping contemporary, accessible healthcare services.

On March 20, Ms. Evangeli Bista and Ms. Pisti Krystallidou actively participated in the Round Table on the same theme. Ms. Krystallidou presented “Empathy in Practice: What the Caregiver Gains from Health Professionals”, highlighting the daily challenges and support needs of people caring for patients. Ms. Bista emphasized Kapa3’s role and the use of digital tools in guiding patients effectively.

During her presentation, Ms. Bista outlined how the healthcare system is transforming: from episodic care to continuous support, from hospital-centered services to daily-life integration, and from the healthcare professional as the sole source of knowledge to the patient as an active participant. In this new environment, digital health and patient navigation go beyond mere tools, focusing on the citizen’s ability to use them meaningfully in everyday life.

Special attention was given to the needs of oncology patients, who require not only access to information but also guidance through a complex healthcare system—knowing where to turn, what they are entitled to, and how to manage critical decisions in daily life. In this context, the importance of patient navigation was highlighted, a model that Kapa3 has implemented since its foundation, acting as a bridge between available services and patients’ real needs.

Finally, the digital social assistant “Myrto” was presented, serving as a single reference point for patients, facilitating access to information and services, and translating knowledge into practical, everyday support.

Kapa3’s participation in the Symposium highlighted the importance of combining technological innovation with empathy, confirming that the future of oncology care is not only about personalized treatment but also about personalized understanding of each patient’s needs.

Download our Press Release here 

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 Participation in the 3rd “Mapping the Unknown in Oncology” Conference

Kapa3 actively participated in the conference “Mapping the Unknown in Oncology – From Hospitals to Homes, mapping the future of oncology care”, organized for its third year by the Medical Society for Research and Education under the auspices of HeSMO (Hellenic Society of Medical Oncologists) and the Hellenic Cancer Society, held on February 27–28, 2026 at the Golden Age Hotel in Athens.

During the events on Saturday, February 28, Ms. Evangelí Bista, Head of Operations and Development at the Kapa3 Cancer Patient Guidance Center, took part in the panel titled “e-Health Tools and Educational Platforms: New Paths for Doctors and Patients.” The panel was moderated by Ms. Z. Saridaki and included panelists G. Koukourakis, S. Peroukidis, F. Tyligadas, and Ch. Christodoulou.

In her presentation, titled “Digital Patient Education: The Patient as an Active Partner,” Ms. Bista highlighted the importance of digital transformation in healthcare, which shifts care from episodic to continuous support, moving healthcare from hospitals into patients’ daily lives and empowering patients to become active participants in managing their health.

In this context, Kapa3 announced that for 2026 it will be the only civil society organization fully integrating AI, cybersecurity, and high-performance computing into its processes and services, implementing:

  • An AI-powered digital assistant (chatbot) for immediate patient guidance and support

  • A voice-command system for website accessibility and text-to-speech conversion

  • Service redesign, simplifying processes and reducing bureaucracy

  • An AI-based recommendation system with usage data analysis to personalize services

Special emphasis was placed on patient navigation, as oncology patients need guidance: where to go, what they are entitled to, when to be concerned, and when to wait. Kapa3 addresses this gap, providing not just information but meaningful, personalized guidance within the healthcare system.

The goal is not to add another service but to unite existing services. The next evolution of this model is Myrto, the digital assistant that serves as a reference point, translating knowledge into daily action.

Because the future of oncology is not only personalized treatment but also personalized understanding.

Kapa3’s participation underscores the organization’s commitment to innovation, collaboration, and ethics, demonstrating how technology can significantly enhance the experience and care of oncology patients.

 

 

The “Myrto” Health Navigator : A New Era of Digital Support for Oncology Patients

The “Myrto” Health Navigator brings digital and AI-powered care closer to oncology patients, supporting personalization and equitable access to services.

On the occasion of the recent initiatives implemented by Kapa3 in the context of World Cancer Day, our organization once again highlighted the importance of access, empowerment, and meaningful support for oncology patients. Through awareness actions and public engagement, we reaffirmed our commitment to strengthening patients’ voices and improving their everyday reality.

Throughout its journey, Kapa3 has consistently demonstrated its dedication to supporting oncology patients by bridging gaps in information, accessibility, and social care. Building on this experience, we are now taking the next step forward.

After five years of continuous presence in empowering oncology patients through digital guidance, Kapa3 is expanding its footprint in the field of social accessibility by creating an innovative digital assistant: “Myrto.”
“Myrto” addresses the phenomenon of second-level digital exclusion, transforming digital information into a human, accessible, and meaningful experience. It represents the first Social Artificial Intelligence application in the field of social welfare for oncology patients in Greece.

It goes beyond providing information: it converses, guides, and evolves according to users’ real needs, with an emphasis on both accessibility and psychosocial support.

Our aim is to develop a fully functional chatbot integrated into the Kapa3 website, to train social workers and healthcare professionals in its use, and to substantially reduce the digital divide for vulnerable groups.

“Myrto” will offer holistic and personalized guidance to oncology patients as a true Patient Empowerment e-Navigator, through two main pillars:

  • Patient Advocate: Support with legal and administrative procedures (benefits, patient rights), facilitation of access to social welfare services, and guidance within the local healthcare system.

  • Health Navigator: Provision of essential information for health self-management.

At the same time, the platform will enhance communication, highlight available community resources, and incorporate an innovative health literacy assessment tool, enabling full personalization of the services provided.

The project will be developed, tested, and validated by oncology patients as well as by social workers, legal and financial experts, and consultants in health communication and psychology, both in person and online across Greece.

Your participation could substantially contribute to co-creating a personalized Navigator for every oncology patient, as a multidisciplinary perspective is a key factor in the project’s success.

Upon completion, we expect significant social, health, and scientific impact: improved patient quality of life, strengthened self-management, reduced resource requirements, and the creation of a network of experts and informed patients and professionals.

The Founding Sponsor of the “Myrto”Health Navigator is the TIMA Foundation.

We invite organizations, professionals, and stakeholders to become partners in this new chapter of the “Myrto” Health Navigator  by Kapa3 and contribute to building a more accessible, inclusive, and patient-centered healthcare environment.

Evangeli Bista, 

Co-founder Kapa3 – Head of Strategic Partnerships
PhD(c), MBA, MSc, BSc

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Artificial Intelligence (AI) is transforming the fight against cancer.The European Cancer Organisation’s “Harnessing AI for Cancer Care in Europe” report

Artificial Intelligence (AI) is transforming the fight against cancer, enabling machines to learn, reason, and assist humans in detecting, diagnosing and treating the disease more accurately and efficiently. It works by analysing vast amounts of data, learning patterns, and making predictions or recommendations to support human decision-making.

Cancer care is rapidly transforming with the use of AI, which serves as a powerful tool in prevention, detection, treatment and research of the disease. The European Cancer Organisation’s “Harnessing AI for Cancer Care in Europe” report states that AI has the potential to transform every stage of the cancer pathway. Simultaneously, the report emphasises the need for AI to be used responsibly, by protecting patients, upholding ethical standards, and aligning with European values, to ensure its benefits are delivered fairly and effectively across healthcare systems.

The Promise of AI in Cancer Care

The report highlights several ways AI can improve cancer outcomes across the care pathway. In primary prevention, AI can analyse genetic, environmental, and lifestyle data to identify high-risk patients and guide preventive strategies before symptoms appear. For early detection, AI can dramatically speed up screening, reducing test interpretation from days to hours, improving accuracy, and lowering missed diagnoses. In diagnostics, deep-learning models trained on large datasets can detect even the smallest lesions, prioritise urgent cases, and support more precise diagnoses. AI also enables personalised treatment by integrating tumour genomics, imaging data, and real-world outcomes to help clinicians select the most effective therapies for individual patients. Finally, in drug development, AI can identify promising compounds and targets, shortening traditional development cycles and discovering new uses for existing medicines.

Challenges That Cannot Be Ignored

However, the report also highlights significant risks associated with AI in cancer care. Key concerns include regulatory gaps as AI tools advance faster than current rules, making it challenging to ensure they remain safe, accurate, and accountable. Many promising AI systems require further validation in real-world clinical settings, as untested tools could lead to misdiagnoses or unsafe decisions. Bias and inequity are also risks, since AI trained on unrepresentative data may produce less accurate recommendations for specific patient groups. Implementation barriers, such as limited infrastructure, funding, and trained staff, can hinder the integration of AI into everyday healthcare. Finally, trust issues may arise, as both patients and clinicians need to understand and have confidence in AI systems for them to be effectively adopted.

Policy Recommendations: A Roadmap for Safe and Effective Use

To tackle these challenges, the report puts forward four key recommendations. First, it calls for national standards and validation frameworks, including speciality-specific rules and post-market monitoring of AI tools. Second, it emphasises the importance of training and literacy, proposing pan-European AI education to ensure that at least 50% of oncology professionals are confident in using AI by 2030. Third, the report urges robust regulatory guidance and oversight, including EU-wide support for data protection under GDPR, implementation of the AI Act, and strong patient engagement to ensure clinical accountability. Finally, it highlights the need for investment in data infrastructure, leveraging the European Health Data Space to harmonise systems, modernise cancer registries, and build representative datasets that support safe and effective AI deployment.

Why This Matters for Kapa3

Building on these advancements, K3 is preparing to launch its digital assistant, “Myrto”, in 2026. Designed to harness the power of AI, “Myrto” will support patients and healthcare professionals across the cancer care pathway. By integrating cutting-edge AI capabilities with user-friendly guidance, “Myrto” exemplifies K3’s commitment to improving outcomes, streamlining workflows, and empowering both patients and clinicians in Europe’s rapidly evolving healthcare landscape.

To see the full article, please click here.

https://www.europeancancer.org/resources/publications/harnessing-ai-for-cancer-care-in-europe.html

When Art Meets Science: How CREATE Platform May Strengthen Emotional Regulation in Cancer Care

At Kapa3, we recognize that cancer affects far more than the body, challenging the emotions, sense of self, relationships, and quality of life of those suffering. Despite the high prevalence of co-occuring mental health issues such as anxiety and depression, access to mental health services remains limited. This gap between patient needs and healthcare provisions is precisely what motivated us to help develop CREATE, an innovative digital platform designed to support emotional resilience through a powerful combination of art, technology, and emotional engagement (Ladas et al., 2025).

The CREATE (Creative and Resilience through Arts, Technology, and Emotions) platform uses computerised cognitive training (CCT) designed to enhance emotional regulation by integrating working memory training, engagement with famous artwork, and creative emotional expression. Unlike other platforms, it only targets one cognitive function: working memory. Evidence suggests that focusing on a single cognitive function is more effective than targeting multiple ones. Working memory in particular has been found to influence emotional regulation, a skillset with established benefits for anxiety and depression.

CREATE therefore introduces a unified framework that addresses cognitive function, emotional expression, and biological influences such as sleep quality and dopamine activity. Such digital health solutions are increasingly recognized as promising alternatives to standard psychotherapy, offering greater accessibility and affordability while still capable of reducing symptoms of depression and anxiety.

Findings from the pilot study on CREATE were very promising; the participants found the platform easy to use and enjoyable, and showed increased emotional and creative engagement. Although this early research focused on feasibility and validity rather than therapeutic effectiveness, initial findings indicate improvements in emotional regulation. Importantly, the study demonstrated positive relationships between working memory, emotional regulation, and expression of emotion, while also suggesting that sleep and dopamine may mediate these effects.

These insights highlight the importance of lifestyle and biological data in developing personalized digital mental health tools. It is well established in neuroscience that working memory plays a central role in emotional regulation. A stronger working memory allows individuals to better cope with distressing thoughts, shift their attention, and respond more calmly to challenges. For people living with cancer, supporting these cognitive and emotional capacities makes daily life more manageable. Improved thinking skills can facilitate treatment adherence, informed decision-making, and a more effective management of the emotional turbulence that often accompanies illness.

The study relied on a convenience sample made up mostly of cancer-related healthcare professionals, and only one cancer survivor participated. To address this limitation, the next phase of research will focus entirely on cancer patients and survivors. Their unique challenges, including cancer-related fatigue and treatment-related cognitive changes, will be central to refining the platform and ensuring that CREATE is tailored to the needs of those it aims to benefit the most. This creates not only a more impactful intervention but also empowers patients to have a voice in shaping the future of supportive cancer care.

As we look ahead, CREATE offers a hopeful vision for digital mental-health support. It is scalable, affordable, and adaptable, making it especially valuable for people who lack access to mental health care. Intervening early and supporting emotional well-being throughout treatment and survivorship may reduce the long-term strain on healthcare services associated with mental health conditions.  As cancer treatment continues to evolve, we must make sure that psychological care develops along with it. And CREATE does just that.

Read the full study

References

Ladas, A. I., Katsoridou, C., Gravalas, T., Klados, M. A., Stravoravdi, A. S., Tsompanidou, N., Fragkedaki, A., Bista, E., Chorafa, T., Petrovic, K., Vlotinou, P., Tsiakiri, A., Papazisis, G., & Frantzidis, C. A. (2025). Creativity and REsilience Through Arts, Technology and Emotions: A Pilot Study on the Feasibility and Validity of the CREATE Platform. Brain Sciences, 15(11), 1171.

‌Article by Despina Chrysostomidou, Psychologist, for Kapa3 Research Insights